DOD Toxic Exposures, Clinical Trial Award

The summary for the DOD Toxic Exposures, Clinical Trial Award grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Dept of the Army USAMRAA, which is the U.S. government agency offering this grant.
DOD Toxic Exposures, Clinical Trial Award: The TERP CTA supports the rapid implementation of clinical trials with the potential to have a significant impact on the prevention, treatment, or management of symptoms, diseases, or conditions associated with or resulting from military-related toxic exposures. To meet the intent of the award mechanism, applications must address at least one of the FY23 TERP Programmatic Goals and at least one of the FY23 TERP Topic Areas.Proposed projects may range from small proof-of-concept clinical trials (e.g., pilot, first-in-human, phase 0) designed to demonstrate the feasibility or inform the design of more advanced trials through large-scale trials to determine efficacy in relevant patient populations. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. It is anticipated that outcomes from studies funded by this award will follow a clinical development plan that advances the research to U.S. Food and Drug Administration (FDA) device or drug approval and/or establishment of clinical practice guidelines, as applicable.Applications to the TERP CTA mechanism must support a clinical trial and may not be used for animal or other preclinical research studies. The application will be withdrawn if the proposed research is not a clinical trial.
Federal Grant Title: DOD Toxic Exposures, Clinical Trial Award
Federal Agency Name: Dept of the Army USAMRAA (DOD-AMRAA)
Grant Categories: Science and Technology
Type of Opportunity: Discretionary
Funding Opportunity Number: HT9425-23-TERP-CTA
Type of Funding: Cooperative Agreement
CFDA Numbers: 12.420
CFDA Descriptions: Information not provided
Current Application Deadline: October 4th, 2023
Original Application Deadline: October 4th, 2023
Posted Date: July 7th, 2023
Creation Date: July 7th, 2023
Archive Date: November 3rd, 2023
Total Program Funding: $8,800,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards: 3
Cost Sharing or Matching: No
Last Updated: July 7th, 2023
Applicants Eligible for this Grant
Unrestricted (i.e., open to any type of entity below), subject to any clarification in text field entitled "Additional Information on Eligibility"
Grant Announcement Contact
CDMRP Help Desk
Phone: 301-682-5507
Email: [email protected]
CDMRP Help Desk
Similar Government Grants
DoD Ovarian Cancer, Ovarian Cancer Clinical Trial Academy - Early-Career Investigator Awar...
DoD Ovarian Cancer Ovarian Cancer Academy - Early-Career Investigator Award
DoD Peer Reviewed Medical, Impact Award
DoD Peer Reviewed Medical, Lifestyle and Behavioral Health Interventions Research Award
DoD Peer Reviewed Medical, Discovery Award
FY2006 Deployed War Fighter Protection Research Program
Department of Defense (DOD) Fiscal Year 2003 (FY03) Breast Cancer Research Program (BCRP)C...
Department of Defense (DOD) Fiscal Year 2004 (FY04) Breast Cancer Research Program (BCRP) ...
More Grants from the Dept of the Army USAMRAA
DoD Ovarian Cancer Ovarian Cancer Academy - Early-Career Investigator Award
DoD Peer Reviewed Medical, Impact Award
DoD Peer Reviewed Medical, Technology/Therapeutic Development Award

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com